Show simple item record

dc.contributor.authorMcDonald, A
dc.contributor.authorThomas, E
dc.contributor.authorDaigle, S
dc.contributor.authorMorschhauser, F
dc.contributor.authorSalles, G
dc.contributor.authorRibrag, V
dc.contributor.authorMckay, P
dc.contributor.authorTilly, H
dc.contributor.authorSchmitt, A
dc.contributor.authorBatlevi, CL
dc.contributor.authorFruchart, C
dc.contributor.authorJohnson, P
dc.contributor.authorDickinson, M
dc.contributor.authorOpat, S
dc.contributor.authorJurczak, W
dc.contributor.authorCartron, G
dc.contributor.authorLamy, T
dc.contributor.authorZinzani, L
dc.contributor.authorAssouline, S
dc.contributor.authorRadford, John A
dc.contributor.authorGribben, G
dc.contributor.authorHaioun, C
dc.contributor.authorChaidos, A
dc.contributor.authorLe Gouill, S
dc.contributor.authorClawson, A
dc.contributor.authorLarus, J
dc.contributor.authorBlakemore, J
dc.date.accessioned2019-03-29T14:22:32Z
dc.date.available2019-03-29T14:22:32Z
dc.date.issued2018en
dc.identifier.citationMcDonald A, Thomas E, Daigle S, Morschhauser F, Salles G, Ribrag V, et al.Updated report on identification of molecular predictors of tazemetostat response in an ongoing NHL phase 2 study. Blood. 2018;132.en
dc.identifier.doi10.1182/blood-2018-99-115132en
dc.identifier.urihttp://hdl.handle.net/10541/621676
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1182/blood-2018-99-115132en
dc.titleUpdated report on identification of molecular predictors of tazemetostat response in an ongoing NHL phase 2 studyen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentThe Christie NHS Foundation Trust, Manchesteren
dc.identifier.journalBlooden
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record